Sanofi Signs pCPA Letter of Intent for Sarclisa in Canada
Sanofi said it completed negotiations with the pan-Canadian Pharmaceutical Alliance and signed a letter of intent for Sarclisa in first-line, transplant-ineligible multiple myeloma.
Sanofi said it completed negotiations with the pan-Canadian Pharmaceutical Alliance and signed a letter of intent for Sarclisa in first-line, transplant-ineligible multiple myeloma.